Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Advantages of conducting clinical trials in the CIS countries, Georgia and Ukraine

Pyatigorskaya N. V., Simeniv S. Y., Kryuchkov D. V., Malikov A. Y., Rogov E. S., Chertishchev N. V.
Journal of Pharmaceutical Sciences and Research
Vol.10, Issue7, P. 1852-1855
Опубликовано: 2018
Тип ресурса: Статья
Аннотация:
The purpose of this review is to examine the current state of the clinical trial market in the CIS, Ukraine and Georgia from the perspective of new opportunities for conducting clinical research in these countries. Russian clinical trial legislation is harmonized with global industry standards not only on the national level, but also on the level of international unions. An agreement of unified principles and rules for the circulation of drugs and medical devices came into force on February 12, 2016 in the Eurasian Economic Union (EAEU), which includes Belarus, Kazakhstan, Armenia and Kyrgyzstan additionally to Russia as of March 2017. High performance quality and professional competence of the investigators, accessible and diverse population of patients, changes and harmonization of legislation as well as system of clinical trial conduct in general, make the CIS countries, including Georgia and Ukraine, quite attractive for conducting both international and local clinical studies of d
Ключевые слова:
Clinical trials in CIS; CRO; Current state of a clinical trial market; Harmonization of legislation; Ukraine and Georgia
accreditation; Article; clinical practice; clinical trial (topic); decision making; drug industry; drug marketing; education program; Georgia (republic); health care; health insurance; human; law; practice guideline; prevalence; Ukraine; USSR; world health organization
Язык текста: Английский
ISSN: 0975-1459
Pyatigorskaya N. V. Natal`ya Valeryevna 1965-
Simeniv S. Y.
Kryuchkov D. V. Dmitrij Vitalyevich 1980-
Malikov A. Y.
Rogov E. S.
Chertishchev N. V.
Пятигорская Н. В. Наталья Валерьевна 1965-
Сименив С. Y.
Крючков Д. В. Дмитрий Витальевич 1980-
Маликов А. Y.
Рогов Е. С.
Чертишчев Н. В.
Advantages of conducting clinical trials in the CIS countries, Georgia and Ukraine
Текст визуальный непосредственный
Journal of Pharmaceutical Sciences and Research
Vol.10, Issue7 P. 1852-1855
2018
Статья
Clinical trials in CIS CRO Current state of a clinical trial market Harmonization of legislation Ukraine and Georgia
accreditation Article clinical practice clinical trial (topic) decision making drug industry drug marketing education program Georgia (republic) health care health insurance human law practice guideline prevalence Ukraine USSR world health organization
The purpose of this review is to examine the current state of the clinical trial market in the CIS, Ukraine and Georgia from the perspective of new opportunities for conducting clinical research in these countries. Russian clinical trial legislation is harmonized with global industry standards not only on the national level, but also on the level of international unions. An agreement of unified principles and rules for the circulation of drugs and medical devices came into force on February 12, 2016 in the Eurasian Economic Union (EAEU), which includes Belarus, Kazakhstan, Armenia and Kyrgyzstan additionally to Russia as of March 2017. High performance quality and professional competence of the investigators, accessible and diverse population of patients, changes and harmonization of legislation as well as system of clinical trial conduct in general, make the CIS countries, including Georgia and Ukraine, quite attractive for conducting both international and local clinical studies of d